Keyphrases
Atrial Fibrillation
100%
Persistent Atrial Fibrillation
37%
Implantable Defibrillator
18%
Non-ischemic Systolic Heart Failure
14%
Hazard Ratio
13%
Cardioverter-defibrillator Implantation
13%
New-onset Atrial Fibrillation
13%
Acute Myocardial Infarction
13%
Sinus Rhythm
12%
All-cause Mortality
12%
CARISMA
12%
Catheter Ablation
12%
Randomized Clinical Trial
12%
P-wave Velocity
12%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
12%
Confidence Interval
11%
Left Ventricular Systolic Dysfunction
10%
Left Ventricular Ejection Fraction
10%
Acute Coronary Syndrome
9%
Heart Failure Patients
9%
Cardiovascular Mortality
9%
Rate Control
9%
Heart Failure
8%
Copenhagen City Heart Study
8%
Plasma Aldosterone Concentration
8%
Extended Follow-up
8%
Ischemic Heart Failure
8%
Empagliflozin
8%
Third-degree Atrioventricular Block
8%
Multidetector Computed Tomography
8%
Left Ventricular Systolic Function
8%
Antiarrhythmic Drugs
8%
Cardiac Function
8%
Type 2 Diabetic Patients
8%
Insulin
8%
Type I Diabetes
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Interleukin-6
8%
Congestive Heart Failure
7%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
7%
Arrhythmia
7%
Ventricular Arrhythmia
7%
Mortality Hazard
7%
Coronary Artery Disease
7%
Atrial Fibrillation Recurrence
6%
Major Adverse Cardiovascular Events
6%
High Burden
6%
Paroxysmal Atrial Fibrillation
6%
Holter Recording
6%
Incident Atrial Fibrillation
6%
Medicine and Dentistry
Atrial Fibrillation
76%
Cardiovascular System
31%
Implantable Automatic Defibrillator
21%
Permanent Atrial Fibrillation
16%
Heart Failure
13%
P Wave
12%
Hazard Ratio
12%
Cardiovascular Disease
12%
Electrocardiogram
10%
Apoplexy
10%
Systolic Heart Failure
10%
Randomized Controlled Trial
10%
Systolic Function
10%
Sinus Rhythm
10%
Third-Degree Atrioventricular Block
9%
Acute Coronary Syndrome
9%
Heart Left Ventricle Ejection Fraction
9%
Symptom
9%
Heart Function
9%
Amino Terminal Sequence
8%
Acute Heart Infarction
8%
Empagliflozin
8%
Heart Muscle Ischemia
8%
Randomized Clinical Trial
8%
Multidetector Computed Tomography
8%
Patient with Type 2 Diabetes
8%
New-Onset Atrial Fibrillation
8%
Systematic Review
8%
Faintness
8%
Urokinase Receptor
8%
Congestive Heart Failure
8%
Persistent Atrial Fibrillation
8%
Cardiac Dysrhythmia
7%
Brain Natriuretic Peptide
7%
Biological Marker
7%
Natriuretic Factor
6%
Fatty Acid
6%
Coronary Artery Disease
6%
All Cause Mortality
6%
Maturity Onset Diabetes of the Young
6%
Diastolic Dysfunction
6%
Left Ventricular Systolic Dysfunction
6%
Prevalence
5%
Paroxysmal Atrial Fibrillation
5%
Cardiac Magnetic Resonance Imaging
5%
Autonomic Neuropathy
5%
Revascularization
5%
